FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Eva Galizia

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Physiology

Co-author Network

Publications

TOP 3
MARIO SCARTOZZI; R Silva; alberto zaniboni; Italo Bearzi; S Biagetti; T Biscotti; Alfredo Falcone; Eva Galizia; R Giampieri; Lucio Giustini; Fotios Loupakis; E Maccaroni; Alessandra Mandolesi; Stefano Cascinu
Analysis of HER-3, insulin growth factor-1, nuclear factor-kB and epidermal growth factor receptor gene copy number in the prediction of clinical outcome for K-RAS wild-type colorectal cancer patients receiving irinotecan-cetuximab.
MARIO SCARTOZZI; Laura Belvederesi; M Bianconi; A Bittoni; M Del Prete; L Faloppi; Eva Galizia; R Giampieri; Cristian Loretelli; E Maccaroni; Stefano Cascinu
Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients.
MARIO SCARTOZZI; Michela Del Prete; Italo Bearzi; Laura Belvederesi; Francesca Bianchi; Maristella Bianconi; Alessandro Bittoni; Luca Faloppi; Eva Galizia; Riccardo Giampieri; Cristian Loretelli; Alessandra Mandolesi; Mirco Pistelli; Stefano Cascinu
Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Eva Galizia (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: MARIO SCARTOZZI; R Silva; alberto zaniboni; Italo Bearzi; S Biagetti; T Biscotti; Alfredo Falcone; Eva Galizia; R Giampieri; Lucio Giustini; Fotios Loupakis; E Maccaroni; Alessandra Mandolesi; Stefano Cascinu
Analysis of HER-3, insulin growth factor-1, nuclear factor-kB and epidermal growth factor receptor gene copy number in the prediction of clinical outcome for K-RAS wild-type colorectal cancer patients receiving irinotecan-cetuximab.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(7):1706-12.
2012: MARIO SCARTOZZI; Laura Belvederesi; M Bianconi; A Bittoni; M Del Prete; L Faloppi; Eva Galizia; R Giampieri; Cristian Loretelli; E Maccaroni; Stefano Cascinu
Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients.
British journal of cancer 2012;106(5):799-804.
2012: MARIO SCARTOZZI; Michela Del Prete; Italo Bearzi; Laura Belvederesi; Francesca Bianchi; Maristella Bianconi; Alessandro Bittoni; Luca Faloppi; Eva Galizia; Riccardo Giampieri; Cristian Loretelli; Alessandra Mandolesi; Mirco Pistelli; Stefano Cascinu
Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients.
PloS one 2012;7(7):e38192.
2011: Stefano Cascinu; Francesco Ferraù; Eva Galizia; Roberto Labianca; Gabriele Luppi; Francesca Pucci; Rossana Berardi; Giordano Domenico Beretta; Rosa Rita Silva; MARIO SCARTOZZI
Pegylated liposomal doxorubicin, 5-fluorouracil and cisplatin versus mitomycin-C, 5-fluorouracil and cisplatin for advanced gastric cancer: a randomized phase II trial.
Cancer chemotherapy and pharmacology 2011;68(1):37-43.
2011: MARIO SCARTOZZI; Italo Bearzi; Alessandra Mandolesi; R Giampieri; L Faloppi; Eva Galizia; Fotios Loupakis; alberto zaniboni; Fausto Zorzi; T Biscotti; Roberto Labianca; Alfredo Falcone; Stefano Cascinu
Epidermal growth factor receptor (EGFR) gene promoter methylation and cetuximab treatment in colorectal cancer patients.
British journal of cancer 2011;104(11):1786-90.
2011: Mirco Pistelli; MARIO SCARTOZZI; Rossana Berardi; Alessandro Bittoni; Eva Galizia; Stefano Cascinu
Second-line chemotherapy with irinotecan, 5-fluorouracil and leucovorin (FOLFIRI) in relapsed or metastatic gastric cancer: lessons from clinical practice.
Tumori 2011;97(3):275-9.
2011: MARIO SCARTOZZI; C Loretelli; Italo Bearzi; Alessandra Mandolesi; Eva Galizia; A Onofri; M Pistelli; A Bittoni; Rossana Berardi; Stefano Cascinu
Allele polymorphisms of tumor integrins correlate with peritoneal carcinosis capability of gastric cancer cells in radically resected patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(4):897-902.
2011: MARIO SCARTOZZI; Walter Siquini; Eva Galizia; Pierpaolo Stortoni; Cristina Marmorale; Rossana Berardi; Aroldo Fianchini; Stefano Cascinu
The timing of surgery for resectable metachronous liver metastases from colorectal cancer: Better sooner than later? A retrospective analysis.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2011;43(3):194-8.
2011: Francesca Bianchi; M Raponi; F Piva; A Viel; Italo Bearzi; Eva Galizia; Raffaella Bracci; Laura Belvederesi; Cristian Loretelli; C Brugiati; F Corradini; D Baralle; Riccardo Cellerino
An intronic mutation in MLH1 associated with familial colon and breast cancer.
Familial cancer 2011;10(1):27-35.
2011: MARIO SCARTOZZI; Alessandra Mandolesi; Riccardo Giampieri; Alessandro Bittoni; Chiara Pierantoni; alberto zaniboni; Eva Galizia; Lucio Giustini; Rosa Rita Silva; Renato Bisonni; Rossana Berardi; Tommasina Biscotti; Simona Biagetti; Italo Bearzi; Stefano Cascinu
The role of HER-3 expression in the prediction of clinical outcome for advanced colorectal cancer patients receiving irinotecan and cetuximab.
The oncologist 2011;16(1):53-60.
2010: MARIO SCARTOZZI; Alessandra Mandolesi; Riccardo Giampieri; Chiara Pierantoni; Fotios Loupakis; alberto zaniboni; Eva Galizia; Lucio Giustini; Rosa Rita Silva; Renato Bisonni; Rossana Berardi; Simona Biagetti; Stefano Menzo; Alfredo Falcone; Italo Bearzi; Stefano Cascinu
Insulin-like growth factor 1 expression correlates with clinical outcome in K-RAS wild type colorectal cancer patients treated with cetuximab and irinotecan.
International journal of cancer. Journal international du cancer 2010;127(8):1941-7.
2010: MARIO SCARTOZZI; Paola Mazzanti; Riccardo Giampieri; Rossana Berardi; Eva Galizia; S Gasparini; L Zuccatosta; Stefano Cascinu
Clinical predictive factors for advanced non-small cell lung cancer (NSCLC) patients receiving third-line therapy: Selecting the unselectable?
Lung cancer (Amsterdam, Netherlands) 2010;68(3):433-7.
2010: MARIO SCARTOZZI; Mirco Pistelli; Alessandro Bittoni; Riccardo Giampieri; Eva Galizia; Rossana Berardi; Luca Faloppi; Michela Del Prete; Stefano Cascinu
Novel perspectives for the treatment of gastric cancer: from a global approach to a personalized strategy.
Current oncology reports 2010;12(3):175-85.
2010: Eva Galizia; Gessica Giorgetti; Gina Piccinini; Alfredo Santinelli; Cristian Loretelli; Francesca Bianchi; Daniela Gagliardini; Giovanna Carbonari; Eleonora Pisa; Laura Belvederesi; Raffaella Bracci; Concetta Ferretti; Fabio Corradini; Riccardo Cellerino
BRCA1 expression in triple negative sporadic breast cancers.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 2010;32(1):24-9.
2009: MARIO SCARTOZZI; Italo Bearzi; Alessandra Mandolesi; Eva Galizia; Chiara Pierantoni; Fotios Loupakis; Rossana Berardi; alberto zaniboni; Antonello Quadri; Fausto Zorzi; Simona Biagetti; Cristian Loretelli; Tommasina Biscotti; Roberto Labianca; Gianluca Masi; Alfredo Falcone; Stefano Cascinu
Epidermal growth factor receptor gene promoter methylation in primary colorectal tumors and corresponding metastatic sites: a new perspective for an "old" therapeutic target.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 2009;31(6):417-23.
2009: MARIO SCARTOZZI; Alessandro Bittoni; Mirco Pistelli; Eva Galizia; Rossana Berardi; Riccardo Giampieri; Luca Faloppi; Stefano Cascinu
Toward molecularly selected chemotherapy for advanced gastric cancer: state of the art and future perspectives.
Cancer treatment reviews 2009;35(5):451-62.
2009: Francesca Bianchi; Eva Galizia; Romina Catalani; Laura Belvederesi; Concetta Ferretti; Fabio Corradini; Riccardo Cellerino
CAT25 is a mononucleotide marker to identify HNPCC patients.
The Journal of molecular diagnostics : JMD 2009;11(3):248-52.
2009: MARIO SCARTOZZI; Italo Bearzi; Alessandra Mandolesi; Chiara Pierantoni; Fotios Loupakis; alberto zaniboni; Francesca Negri; Antonello Quadri; Fausto Zorzi; Eva Galizia; Rossana Berardi; Tommasina Biscotti; Roberto Labianca; Gianluca Masi; Alfredo Falcone; Stefano Cascinu
Epidermal Growth Factor Receptor (EGFR) gene copy number (GCN) correlates with clinical activity of irinotecan-cetuximab in K-RAS wild-type colorectal cancer: a fluorescence in situ (FISH) and chromogenic in situ hybridization (CISH) analysis.
BMC cancer 2009;9():303.
2008: Laura Belvederesi; Francesca Bianchi; Eva Galizia; Cristian Loretelli; Raffaella Bracci; Romina Catalani; Monica Amati; Riccardo Cellerino
MSH2 missense mutations and HNPCC syndrome: pathogenicity assessment in a human expression system.
Human mutation 2008;29(11):E296-309.
2008: C Braconi; Raffaella Bracci; Italo Bearzi; Francesca Bianchi; A Costagliola; Romina Catalani; A Mandolesi; R Ranaldi; Eva Galizia; Stefano Cascinu; G Rossi; L Giustini; L Latini; N Valeri; Riccardo Cellerino
KIT and PDGFRalpha mutations in 104 patients with gastrointestinal stromal tumors (GISTs): a population-based study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(4):706-10.
2007: MARIO SCARTOZZI; Eva Galizia; Lorena Verdecchia; Rossana Berardi; Stefania Antognoli; Silvia Chiorrini; Stefano Cascinu
Chemotherapy for advanced gastric cancer: across the years for a standard of care.
Expert opinion on pharmacotherapy 2007;8(6):797-808.
2007: Francesca Bianchi; Eva Galizia; Raffaella Bracci; Laura Belvederesi; Romina Catalani; Cristian Loretelli; G Giorgetti; C Ferretti; Italo Bearzi; Emilio Porfiri; Riccardo Cellerino
Effectiveness of the CRCAPRO program in identifying patients suspected for HNPCC.
Clinical genetics 2007;71(2):158-64.
2007: Francesca Bianchi; Eva Galizia; Emilio Porfiri; Laura Belvederesi; Romina Catalani; Cristian Loretelli; Raffaella Bracci; Italo Bearzi; Chiara Turchi; Alessandra Viel; Riccardo Cellerino
A missense germline mutation in exon 7 of the MSH2 gene in a HNPCC family from center-Italy.
Familial cancer 2007;6(1):97-102.
2006: MARIO SCARTOZZI; Eva Galizia; Lorena Verdecchia; Rossana Berardi; Graziano Francesco; Vincenzo Catalano; Paolo Giordani; Davide Mari; Rosa Rita Silva; Cristina Marmorale; C Zingaretti; Stefano Cascinu
Lymphatic, blood vessel and perineural invasion identifies early-stage high-risk radically resected gastric cancer patients.
British journal of cancer 2006;95(4):445-9.
2006: Laura Belvederesi; Francesca Bianchi; Cristian Loretelli; Daniela Gagliardini; Eva Galizia; Raffaella Bracci; Saverio Rosati; Italo Bearzi; Alessandra Viel; Riccardo Cellerino; Emilio Porfiri
Assessing the pathogenicity of MLH1 missense mutations in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with clinical, genetic and functional features.
European journal of human genetics : EJHG 2006;14(7):853-9.
2005: Rossana Berardi; G Grilli; E Romagnoli; T Saladino; Federica Freddari; T Tamburrano; Eva Galizia; G Carbonari; C Mariani; Chiara Braconi; Chiara Pierantoni; Nicola Battelli; MARIO SCARTOZZI; Stefano Cascinu
[Paraneoplastic syndromes: a review].
La Clinica terapeutica 2005;156(6):281-8.
2005: MARIO SCARTOZZI; Eva Galizia; Graziano Francesco; Vincenzo Catalano; Rossana Berardi; Anna Maria Baldelli; Enrica Testa; Davide Mari; Rosa Rita Silva; Stefano Cascinu
Over-DI dissection may question the value of radiotherapy as a part of an adjuvant programme in high-risk radically resected gastric cancer patients.
British journal of cancer 2005;92(6):1051-4.
2004: Eva Galizia; Rossana Berardi; MARIO SCARTOZZI; Stefano Cascinu
A cost-benefit analysis of chemotherapy for gastric cancer.
Expert opinion on pharmacotherapy 2004;5(10):2109-14.
2004: MARIO SCARTOZZI; Eva Galizia; Federica Freddari; Rossana Berardi; Riccardo Cellerino; Stefano Cascinu
Molecular biology of sporadic gastric cancer: prognostic indicators and novel therapeutic approaches.
Cancer treatment reviews 2004;30(5):451-9.
2003: Rossana Berardi; MARIO SCARTOZZI; Eva Galizia; Stefano Cascinu
Adjuvant chemotherapy in gastric cancer. The Italian experience and review of the literature.
I supplementi di Tumori : official journal of Società italiana di cancerologia ... [et al.] 2003;2(5):S45-7.
2003: MARIO SCARTOZZI; M De Nictolis; Eva Galizia; P Carassai; Francesca Bianchi; Rossana Berardi; Rosaria Gesuita; Andrea Piga; Riccardo Cellerino; Emilio Porfiri
Loss of hMLH1 expression correlates with improved survival in stage III-IV ovarian cancer patients.
European journal of cancer (Oxford, England : 1990) 2003;39(8):1144-9.
2002: MARIO SCARTOZZI; Francesca Bianchi; Saverio Rosati; Eva Galizia; Annalisa Antolini; Cristian Loretelli; Andrea Piga; Italo Bearzi; Riccardo Cellerino; Emilio Porfiri
Mutations of hMLH1 and hMSH2 in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with microsatellite instability and abnormalities of mismatch repair protein expression.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(5):1203-8.